Clinical Trials in Minneapolis

Showing 7281-7300 of 11,007 trials

Driveline Silicone Skin Interface Registry

NCT01577433

The purpose of this observational registry is to determine the freedom from driveline (DL) infection events in subjects implanted with a HeartMate II LVAD in whom only the silicone portion of the DL is externalized resulting in a silicone skin interface (SSI)

Driveline Heart-assisted Device Related Infection

Abbott Medical Devices400 participantsStarted May 2012

New Haven, Connecticut, United States • Tampa, Florida, United States • Atlanta, Georgia, United States +12 more locations

COMPLETEDPhase 1< 1 mile

A Study of LY2928057 in Hemodialysis Participants

NCT01991483

This study will evaluate the safety of LY2928057 and how LY2928057 affects hemoglobin in hemodialysis participants. This study will involve multiple doses of LY2928057 given during a 6 week period either after a participant discontinues or reduces treatment to stimulate red blood cells. This study will last up to 26 weeks for each participant.

Renal Insufficiency, ChronicKidney Disease, Chronic

Eli Lilly and Company28 participantsStarted Dec 2013

Lakewood, Colorado, United States • Orlando, Florida, United States • Indianapolis, Indiana, United States +1 more locations

Driveline Silicone Skin Interface Registry

A Study of LY2928057 in Hemodialysis Participants

Find Trials by Condition in Minneapolis

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

Study of Binocular Computer Activities for Treatment of Amblyopia

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Inflammation and the Host Response to Injury (Trauma)

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device